Bellus Health Toronto-Listed Shares Double on GSK Takeover
April 18 2023 - 10:42AM
Dow Jones News
By Adriano Marchese
Bellus Health Inc.'s Toronto-listed shares doubled Tuesday
morning after the company agreed to sell itself to British
pharmaceutical and biotechnology giant GSK PLC for $2 billion.
At 10:05 a.m. ET, shares trading in Toronto increased twofold to
C$19.38.
Shareholders of the Laval, Quebec-based drug-development company
will receive $14.75 a share, more than double Monday's U.S.-listed
share price of $7.26.
The deal is expected to close by the third quarter of this
year.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
April 18, 2023 10:27 ET (14:27 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Nov 2023 to Dec 2023
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Dec 2022 to Dec 2023
